Lifespan Pharmacy
Your Onsite Source for Medication and Consultation

PGY2 Oncology Pharmacy Residency Program

The American Society of Health-System Pharmacists (ASHP) accreditation standard provides criteria that every program must meet in order to receive and maintain accreditation. This program follows the ASHP-approved postgraduate year 2 (PGY2) oncology competency areas, goals and objectives. The requirement for this residency program is successful completion of a postgraduate year 1 (PGY1) residency.

While this program follows ASHP standards, the strength of this program is its flexibility: it can be tailored to meet the needs and interests of the individual resident. The mission of our program includes developing a core skill set in hematology/oncology pharmacology, patient care and professional practice.


PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program graduates will be prepared to function independently as hematology/oncology clinical pharmacy specialists and act as an essential member of an interdisciplinary team caring for patients with cancer. Further, graduates will be prepared to function as adjunct faculty for pharmacy students on rotation and in classroom learning experiences at the College of Pharmacy. Finally, the graduate will be prepared for board certification in oncology pharmacy.


The residency program will provide the resident with specific learning/practice experiences designed to enable the resident to expand the scope of his or her practice skills. The program objectives and goals are based on a standard list provided by ASHP and reflect our program’s purpose.

Supervision and Work Ethic

The resident is expected to achieve the objectives of the residency program related to both administrative and professional practice skills. The resident reports to and is supervised by the rotation preceptor and the residency program director. During staffing, the resident is under the supervision of the pharmacist in charge.

Hours of practice vary according to the requirements set forth by the preceptor and director. The resident is expected to be present in body, mind and spirit at all assigned activities of the service they are currently a part of, including medical staff rounding, clinic visits and administrative activities. An eight-hour day is a minimum requirement for physical presence on site during assigned work days.

The residency program is the resident’s most important commitment. Working extra shifts outside the residency program requirements (moonlighting) is strongly discouraged, especially at the beginning of the residency. To work overtime, the resident must be trained in the area. Extra work moonlighting and overtime work must be requested through and approved by the residency director and hours worked will be reported on a monthly basis by each resident. Consideration will be given to residency workload and deliverables assigned and resident standing within the program. 

ASHP logo

The residency program in oncology is conducted by Rhode Island Hospital, Providence, RI, in partnership with the University of Rhode Island and is accredited by the American Society of Health-System Pharmacists.

PGY2 Program Compensation

  • Stipend ($45,675.97)
  • Health, dental and life insurance
  • Holiday, vacation and sick leave
  • Free parking
  • Office space with computer
  • Travel, continuing education allowance


August – November
January – June
  • Hospital Orientation
  • Introduction to residency program and systems
  • Credentialing as an Oncology Pharmacist
  • Palliative Care (4 weeks)
  • Acute Care Hematology/Oncology (each 8 weeks)
  • Ambulatory Hematology/Oncology I (4 weeks)
  • Longitudinal Projects
  • Vizient and ASHP Midyear
  • Ambulatory Hematology/Oncology II & III (each 4 weeks)
  • Investigational Drug Services (4 weeks)
  • Electives (12 weeks)

Longitudinal Experiences
Academia (January – June)
Practice Management (July – June)
Medication Safety (July – June)
Formulary Management (July – June)
Service Commitment (July – June)
Topic Discussions /Journal Club (Weekly, August – June)
Residency Research Project (One per Year) 


Elective Experiences (resident may choose 3):
Bone Marrow Transplant (at UMass Memorial in Worcester, MA)
Infectious Diseases/Antimicrobial Stewardship
Pediatric Hematology/Oncology (Inpatient and Outpatient)
Interpretation and Application of Research Principles

The RPD will attempt to develop other elective rotations per the resident’s interest, if possible.  

More about the Pharmacy Residency Programs